Las revisiones, que examinan los efectos de tres medicamentos adelgazantes, conocidos como agonistas del receptor de GLP-1 (siglas en ingls de pptido glucagonoide de tipo 1), han encontrado que producen una prdida de peso clnicamente significativa en comparacin con un medicamento ficticio (placebo)
What we know about weight loss One of the most familiar effects of GLP-1 medications is weight loss, and that may matter for some people with breast cancer
Over time, this can lead to osteoporosis and frequent falls and fractures
Proper injection technique and provider guidance may help reduce discomfort
The study, Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024, looked at data from the FDA Adverse Event Reporting System on the following GLP-1 agonists: semaglutide, liraglutide, exenatide, and dulaglutide